Article

Price Transparency: The Time Is Now

It is past time for healthcare leaders to start providing greater price transparency for consumers, regardless of the challenges and obstacles to doing so, writes HFMA President and CEO Joseph J. Fifer.

By Joseph J. Fifer, FHFMA, CPA February 25, 2019

Beyond the Mandate: Better Strategies for Price Transparency

Some healthcare organizations have taken the spirit of new price transparency regulations a step further by striving to inform patients in advance about their true out-of-pocket costs for care.

By Laura Ramos Hegwer February 25, 2019

Telehealth Use Among Medicare Patients Limited but Growing

Growth in telehealth use among Medicare beneficiaries is occurring in patients 85 years and older and living in rural areas.

By HFMA February 21, 2019

National Hospital Survey Shares Insight into CMS’s Price Transparency Requirement

Hospitals expressed uncertainty about the usefulness of information supplied in response to CMS’s IPPS transparency requirements, but also recognize that the rule amplifies healthcare industry efforts to provide meaningful price estimates for healthcare services. 

By Jamie Cleverley February 21, 2019

Aligning Executive Compensation to Strategic Priorities

As hospital boards and executives embark on transformational strategies like clinical integration and population health management, finance leaders are key in helping to set performance targets that are appropriate relative to industry-wide statistics as well as past performance.

By David Bjork February 21, 2019

Healthcare Predictions Focus on Innovative Corporate Structures and Alternative Financing

An alternative corporate structure called a “benefit corporation” is at the center of one of 10 predictions issued by BDO. Two others one related to telemedicine and the other related to sources of alternative capital pertain to hospital finance.

By Ed Avis February 21, 2019

An ‘Outside View’ Helps Achieve Return on Analytics

An “outside view” can counter biases and organizational pressures that can skew internal decision-making processes. It also provides a framework for target setting that helps define realistic expected returns.

By Scott R. Engel February 21, 2019

No-Divert Policy, Strategic Growth Help Erlanger Increase Revenue by $300 Million

A strategic plan that focused on growth and expanding specialty services helped Erlanger Health System improve its balance sheet while maintaining high-quality performance. A pay-for-performance program also increased nurse productivity. 

By Laura Ramos Hegwer February 21, 2019

Annual Hospital Costs for Opioid Overdose Patients Approaches $2 Billion

The average cost for an overdose patient who was treated and released totaled $504, but the average cost rose to $11,731 for those that were treated and admitted to a hospital.

By HFMA February 15, 2019

Evaluating Cost-of-Care Progress

Although more time and evidence are needed to prove the efficacy of population-based VBP models, there are other models that may be more appropriate for different populations.

By HFMA February 15, 2019
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-leaderboard' ); } );

{{ loadingHeading }}

{{ loadingSubHeading }}

We’re having trouble logging you in.

For assistance, contact our Member Services Team.

Your session has expired.

Please reload the page and try again.